The Effect of a Vegan Alginate Product on Athletes Recovery and Performance

Sponsor
Per Bendix Jeppesen (Other)
Overall Status
Completed
CT.gov ID
NCT05207332
Collaborator
Future Food Innovation (Industry)
14
1
2
34.7
0.4

Study Details

Study Description

Brief Summary

The feeding strategies during recovery are essential to optimize a subsequent performance. Carbohydrate is a major fuel source during exercise as it has been shown to maintain high rates of carbohydrate oxidation. Protein intake in combination with carbohydrate have been shown to increase Amino acid bioavailability and may alter physiologic responses during exercise, which may be relevant to endurance performance. The goal of this study is to assess the effect of a new developed vegan product on athletes recovery and subsequent performance.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: CHO+PRO
  • Dietary Supplement: CHO
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
14 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
The Effect of a Vegan Alginate Product on Athletes Recovery and Performance
Actual Study Start Date :
Mar 6, 2019
Actual Primary Completion Date :
Jan 25, 2022
Actual Study Completion Date :
Jan 25, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vegan product

Dietary Supplement: CHO+PRO
A vegan product containing carbohydrate and protein

Active Comparator: Control

Dietary Supplement: CHO
containing carbohydrate

Outcome Measures

Primary Outcome Measures

  1. Performance [Aprox. 120 minutes]

    Time-to-exhaustion. Measured by the duration of high intensity exercise performed to exhaustion.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • males between 18-50 years of age

  • moderate to trained individuals with a VO2max > 50 ml/min/kg

Exclusion Criteria:
  • persons diagnosed with metabolic diseases (i.e. Type 2 Diabetes) which relates to the carbohydrate metabolism.

  • persons ingesting prescribed drugs/medicin, supplements or a special diet (i.e. low carbohydrate), which might affect the glykogen synthesis and/or performance.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aarhus University Aarhus Denmark 8000

Sponsors and Collaborators

  • Per Bendix Jeppesen
  • Future Food Innovation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Per Bendix Jeppesen, Associate professor, Ph.D., Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT05207332
Other Study ID Numbers:
  • VEGSPORT
First Posted:
Jan 26, 2022
Last Update Posted:
Jan 26, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 26, 2022